Clinical trial
Flavopiridol in Treating Patients With Recurrent Prostate Cancer
NCT00003256 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00003256 |
|---|---|
| Title | Flavopiridol in Treating Patients With Recurrent Prostate Cancer |
| Official title | A Phase II Trial of Flavopiridol in Patients With Metastatic Androgen Independent Prostate Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | alvocidib |
| Enrollment | 40 |
| Start date | May 1, 1998 |
| Primary completion | Jul 1, 2002 |
| Completion | Apr 1, 2004 |
| First posted | Aug 2, 2004 |
| Last update posted | Feb 11, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: